Paystand Launches the World’s First AR-Centric Dynamic Discounting Application, Powered by Blockchain Smart Contracts
Based on blockchain-powered Ethereum smart contracts, the service enables AR teams to get paid early,…
News
Genmab Announces That AbbVie Will Submit Marketing Authorization Application to European Medicines Agency for Epcoritamab (DuoBody®-CD3xCD20) for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Company Announcement COPENHAGEN, Denmark; July 18, 2022 – Genmab A/S (Nasdaq: GMAB) today announced that…
Axiom Exhibiting at Clinical Operations in Oncology Trials East Coast 2022
TORONTO, July 18, 2022 (GLOBE NEWSWIRE) — Axiom Real-Time Metrics (“Axiom”), the premier provider of…
Verizon adds spectrum for faster speeds, better performance and greater availability of 5G Ultra Wideband
Verizon has started deploying with 100 MHz of C-band spectrum in many markets across the…
Readyhubb Launches Free Innovative Booking Platform and Marketplace for Various Industry Professionals
Female and Black-Owned Tech Startup Allows independent professionals and freelancers to grow their clientele and…
Aptean Strengthens Its Strategic Network in the DACH Region
New partnership with TechVolution brings Aptean’s solutions to medical technology companies in Switzerland Aptean strengthens…
JZZ Technologies, Inc. Launches NAD Product Sales Through its Nutritional Supplements site ActiveLifestyleNutrition.com
Anderson, South Carolina–(Newsfile Corp. – July 18, 2022) – JZZ Technologies Inc., (OTC Pink: JZZI)…
Trellix Finds Business Services Top Target of Ransomware Attacks
Report Details Evolution of Russian Cybercrime, Email Security and Threats to Critical Infrastructure SAN JOSE,…
CF Industries Holdings, Inc. Statement Regarding ITC Injury Determination Concerning Imports of UAN from Russia and Trinidad and Tobago
DEERFIELD, Ill.–(BUSINESS WIRE)–Today, the U.S. International Trade Commission (“ITC”) made a negative final injury determination…
Lefebvre and Lexsoft present Smart Tags and Legal Review, two new tools for document management in law and consultancy firms
Carlos García-Egocheaga, CEO at Lexsoft: “Thanks to the application of AI it is possible to…
Artificial Intelligence continues To Expand The Capabilities Of Cross-Border Payments
Artificial Intelligence (AI) is playing a crucial role in improving the efficiency and security of…
ABVC Notes New Report That Estimates Global Retinal Surgical Instruments Market to Grow to $2.46 Billion by 2028
— Growth to benefit ABVC’s Vitargus medical device product — FREMONT, CA, July 18, 2022…
Acer Therapeutics Announces Resubmission of New Drug Application for ACER-001 for Treatment of UCDs
Acer has notified the FDA in the resubmission that the third-party contract packaging manufacturer is…
Ashvattha Therapeutics Announces Poster Presentation of Preclinical Data on Hydroxyl Dendrimer-Based PET Tracer [18F]OP-801 at the 2022 Alzheimer’s Association International Conference (AAIC)
– Scientific collaborators at Stanford University will present preclinical data on the sensitivity of [18F]OP-801…
Ring Therapeutics Announces Three Presentations at the 41st Annual Meeting of the American Society for Virology (ASV)
CAMBRIDGE, Mass., July 18, 2022 (GLOBE NEWSWIRE) — Ring Therapeutics, a life sciences company founded…
PMV Pharmaceuticals Announces a Clinical Trial Collaboration with Merck to Evaluate PC14586 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced Solid Tumors
Combination trial to be initiated in Q4 2022 CRANBURY, N.J., July 18, 2022 (GLOBE NEWSWIRE)…
Eyenovia Provides Manufacturing Update and Announces Appointment of Bren Kern as SVP of Manufacturing and Operations
New internal manufacturing capabilities to complement existing contract manufacturing relationships NEW YORK, July 18, 2022…
Prometheus Biosciences Completes Enrollment of the ARTEMIS-UC Cohort 1 Phase 2 Study in Ulcerative Colitis
– Global Phase 2 placebo-controlled trial enrolled twice as fast as the industry average, establishing a…
AIM ImmunoTech Announces that Recently Received Director Nominations from Jorgl Activist Group are Invalid
Files Complaint in Federal Court to Compel Activist Group to Reveal True Intentions – Including…
Erasca Announces Clinical Trial Collaboration and Supply Agreement with Eli Lilly and Company to Evaluate ERAS-601 and Cetuximab Combination
ERAS-601, a potential best-in-class SHP2 inhibitor, is being investigated alone and in combination in the…